THEVA Revenue and Competitors

Ismaning,

Location

N/A

Total Funding

Electronics

Industry

Estimated Revenue & Valuation

  • THEVA's estimated annual revenue is currently $2.5M per year.(i)
  • THEVA's estimated revenue per employee is $147,000

Employee Data

  • THEVA has 17 Employees.(i)
  • THEVA grew their employee count by 6% last year.

THEVA's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.7M130%$61.6MN/A
#2
$12.8M582%N/AN/A
#3
$13.2M60-6%N/AN/A
#4
$11.3M53-2%$20.1MN/A
#5
$48.7M185-3%$365KN/A
#6
$29.6M12132%N/AN/A
#7
$19.6M80-14%N/AN/A
#8
$33.1M135-9%N/AN/A
#9
$39.6M14726%N/AN/A
#10
$42.7M16224%$2.9MN/A
Add Company

What Is THEVA?

THEVA uses a unique approach to produce high temperature superconductor wire under the brand name of THEVA Pro-Line. Thanks to its outstanding performance, transporting extremely high electrical current without losses is becoming reality. This is possible due to THEVA's over 20 years of experience in coating technology and equipment engineering. Thanks to its high-power density, our superconductor wire THEVA Pro-Line can replace copper conductors in high-performance applications and open up entirely new design perspectives. Manufacturers of cables, power electronics, industrial drives or power rails also need very reliable material that can be easily processed. We ensure that with our professional quality management. THEVA is also selling the unique measurement system Tapestar which can measure the critical current of any high temperatur superconducting tape with superior resolution and speed.

keywords:N/A

N/A

Total Funding

17

Number of Employees

$2.5M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

THEVA News

2022-04-19 - Computer modelling to aid search for HIV vaccine

... developments in generating more potent computing power, writes Kumitaa Theva Das in part three in a series on vaccines beyond Covid.

2022-04-06 - Follow other countries, give 4th vaccine dose, says virologist

Kumitaa Theva Das. Citing a recent study done in Israel, Kumitaa Theva Das of Universiti Sains Malaysia said the immunity level among the...

2022-03-30 - To fight Omicron XE, second booster may not be necessary ...

Dr Kumitaa Theva Das from Universiti Sains Malaysia said while the "extremely high transmissibility" of the XE variant meant it could become...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.1M2222%N/A
#2
$2.3M23N/AN/A
#3
$2.6M26N/AN/A
#4
N/A3462%N/A
#5
$9.5M3638%N/A